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a  b  s  t  r  a  c  t
Monoamine  oxidase-A  (MAO-A)  is  the  main  enzyme  in  the metabolism  of  the  neuro-
transmitter  serotonin  (5-hydroxytryptamine).  Elevated  activity  of  MAO-A  in  the  brain  may
contribute to the  pathogenesis  of  depressive  disorders.  Plant  ﬂavonoids,  such  as  ﬂavonol
quercetin  and  ﬂavone  luteolin,  have  been  suggested  to be  potential  antidepressant  com-
pounds  because  they  exert  a suppressive  effect  on  the MAO-A  reaction.  We  evaluated  the
effects of these  ﬂavonoids  on  MAO-A  activity  and  protein  level  using  SH-SY5Y  as  model
serotoninergic  nerve  cells.  Quercetin  and  luteolin  were  incorporated  into  SH-SY5Y  cells
rapidly and  converted  to O-methylated  derivatives.  Luteolin  accumulated  in  cells  after  24-
h incubation,  whereas  quercetin  disappeared  completely  from  cell fractions  and culture
medium.  Addition  of  ascorbic  acid prevented  the  disappearance  of  quercetin  and  allowed
it to  exert  its cytotoxicity  (similar  to luteolin)  at >10  M.  Luteolin  and quercetin  were  incor-
porated  into  mitochondria  fractions  within  1-h incubation  and  attenuated  MAO-A  activityhemical  compounds studied in this article:
uercetin (PubChem ID: 5280343
uteolin (PubChem ID: 5280445)
sorhamnetin (PubMed ID: 5281654)
iosmetin (PubMed ID: 5281612)
slightly  but  signiﬁcantly.  After  24-h  incubation,  luteolin  attenuated  MAO-A  activity,  but
quercetin  needed  ascorbic  acid  for its attenuation.  Neither  luteolin  nor  quercetin  signiﬁ-
cantly affected  MAO-A  protein  level.  These  data  suggest  that  luteolin  and  quercetin  can  be
direct inhibitors  of  MAO-A  in  nerve  cells  by targeting  mitochondria.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. Introduction
Monoamine oxidase (MAO) is a ﬂavin enzyme (EC
.4.3.4) located in the outer membranes of mitochon-
ria. Of the two isoenzymes, MAO-A has attracted
onsiderable attention because of its relationship to the
etabolism of the monoamine neurotransmitter serotonin
Abbreviations: MAO-A, monoamine oxidase-A; CNS, central nervous
ystem; DMSO, dimethyl sulfoxide; DMEM,  Dulbecco’s modiﬁed Eagle’s
edium; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate;
CA, bicinchoninic acid.
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E-mail  address: terao@nutr.med.tokushima-u.ac.jp (J. Terao).
http://dx.doi.org/10.1016/j.toxrep.2014.08.016
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(5-hydroxytriptamine) [1]. Depletion of serotonin level in
the  central nervous system (CNS) is suggested to be respon-
sible  (at least in part) for the pathogenesis of depressive
disorders [2]. There is some evidence that MAO-A activity
in  the brain is elevated during depression [3]. Therefore,
it is likely that elevation of MAO-A activity accelerates
serotonin metabolism, thereby resulting in depletion of
serotonin in the brain.
MAO-A  inhibitors, such as clorgyline, have been used
as  antidepressants. However, prolonged intake of these
drugs  may induce so-called “cheese effect,” which is based
on  the inhibition of MAO-A responsible for detoxiﬁca-
tion of exogenous amines in the small intestine [4,5].
Herbal medicines are frequently used for the treatment of
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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depression, along with conventional antidepressants. Sev-
eral  studies have implied the essential role of ﬂavonoids
in the antidepressant effect of herbal medicines [6,7].
In  particular, 3,3′,4′,5,7-pentahydroxyﬂavone, quercetin,
as  well as its structurally related ﬂavonoids, have been
shown to exert antidepressant-like effects in rodent mod-
els  of depression [8–10]. Furthermore, in vitro studies have
shown  that quercetin possesses considerable inhibitory
effects on MAO-A activity in mitochondrial fractions
obtained from mouse brains [11,12].
Our previous study revealed that quercetin is a weak
(but safe) inhibitor of MAO-A in the modulation of sero-
tonin  levels in the brain compared with conventional
MAO-A antidepressants because it does not evoke side
effects  in the small intestine [13]. In addition, we  found
a  remarkable inhibitory effect of a ﬂavone-type ﬂavonoid,
luteolin (3′,4′,5,7-tetrahydroxyﬂavone), on MAO-A activ-
ity  in mitochondria from mouse brains [13] Ishisaka et al.
[14]  and Sasaki et al. [15] demonstrated that luteolin also
possesses signiﬁcant antidepressant-like activity in rodent
studies.  Among ﬂavonoids, ﬂavones and ﬂavonols are sug-
gested  to act as multitarget therapeutic tools for protecting
the  brain [16]. These ﬂavonoids (especially quercetin) are
present  in fruits and vegetables and consumed daily as
ingredients of plant foods. Therefore, the effect of quercetin
and  luteolin on the MAO-A reaction is interesting for the
prevention of depression through foods as well as herbal
medicines. Our in vivo study already found that dietary
quercetin attenuated MAO-A activity in the brain of mouse
[12].  However, exact molecular mechanisms for the action
of  these ﬂavonoids have not been fully clariﬁed. In partic-
ular,  their effects on the regulation of MAO-A expression
have not been investigated yet.
We wished to elucidate the role of quercetin and
luteolin as potential MAO-A modulators in the CNS. We
selected  SH-SY5Y cells as models of serotoninergic neu-
ronal  cells. Then we investigated the effect of quercetin and
luteolin  on MAO-A activity and protein levels, as well as
their  cellular uptake and intracellular metabolism.
2. Materials and methods
2.1.  Chemicals and reagents
Quercetin,  isorhamnetin (3′-O-methyl quercetin), lute-
olin  and diosmetin (4′-O-methyl luteolin) were pur-
chased from Extrasynthese (Genay Cedex, France). Peni-
cillin  (5000 U/mL) and streptomycin (5000 g/mL) were
obtained from Invitrogen (Carlsbad, CA, USA). Sero-
tonin was a product of Nacalai Tesque (Kyoto, Japan).
Kynuramine and Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/Nutrient F-12 Ham (D 8437) were from Sigma-
Aldrich (St. Louis, MO,  USA). Cell Proliferation Reagent
WST-1 was from Roche Diagnostics (Mannheim, Germany).
Other  reagents were of the highest grade available from
commercial sources.2.2.  Cell culture
Human neuroblastoma SH-SY5Y cells were kindly pro-
vided  by Dr. Makoto Naoi (Aichi Gakuin University, Aichi,ports 1 (2014) 639–649
Japan).  Cell cultures were maintained in DMEM/Nutrient
F-12 Ham supplemented with 10% fetal bovine serum,
100 U/mL penicillin and 100 g/mL streptomycin at 37 ◦C
in  a humidiﬁed atmosphere of 5% CO2.
2.3. SH-SY5Y cells viability of SH-SY5Y cells
SH-SY5Y cells (1 × 105 cell/well) were plated on 96-well
microwell plates. After incubation for 24 h, the medium
was  replaced with 100 L of fresh medium containing
quercetin, isorhamnetin, luteolin or diosmetin. These test
ﬂavonoids were dissolved in dimethyl sulfoxide (DMSO)
and  added to culture medium at ﬁnal concentrations 0.1,
1,  10, 50 and 100 M followed by incubation for a fur-
ther 24 h. The ﬁnal concentration of DMSO was  ≤0.5%. Cells
were  treated with 5 L of Cell Proliferation Reagent WST-1
followed by incubation for 2 h under the same conditions.
After shaking of plates thoroughly for 1 min, absorbance
at 450 nm was  measured. Cell viability was  expressed as
percent  of vehicle-treated control.
2.4. Isolation of mitochondrial fractions from SH-SY5Y
cells
Mitochondrial fractions were isolated from SH-SY5Y
cells according to the method of [17] with slight mod-
iﬁcation. Brieﬂy, cells were washed twice with ice-cold
10  mM phosphate-buffered saline (PBS) (pH 7.4) con-
taining 140 mM NaCl and 2.7 mM  KCl. Then, they were
harvested and centrifuged (1200 × g for 5 min  at 4 ◦C). Cell
pellets were resuspended in 800 L of 10 mM PBS (pH 7.4)
containing 320 mM sucrose, and homogenized followed by
centrifugation (700 × g for 10 min  at 4 ◦C). Obtained super-
natants containing mitochondrial fractions were subjected
to  a second centrifugation (12,000 × g for 15 min  at 4 ◦C).
Supernatants from the second centrifugation were dis-
carded  and mitochondrial pellets resuspended with 50 mM
PBS  (pH 7.4). Concentrations of mitochondrial proteins
were determined using a bicinchoninic acid (BCA) Protein
Assay  kit (Pierce, Rockford, IL, USA).
2.5. Determination of MAO-A activity
MAO-A activity was estimated using kynuramine as
MAO-A substrate according to the method described by
[18]  with slight modiﬁcation. The reaction mixture con-
tained  50 mM PBS (pH 7.4), 200 M kynuramine (as a
MAO-A substrate) and 0.4 mg/mL  mitochondrial protein.
The  ﬁnal volume of the reaction mixture was  250 L. Sam-
ples  were incubated at 37 ◦C for 1 h and cooled on ice.
Five-hundred microliters of distilled water, 250 L of 10%
ZnSO4 and 50 L of 1 M NaOH were added. Samples were
boiled at 100 ◦C for 2 min, cooled on ice and centrifuged
(1000 × g for 10 min). Supernatants were diluted by 5
times  with 1 M NaOH. Fluorescence intensity of the reac-
tion  product (4-hydroxylquinoline) was measured with
Ex = 310 nm and Em = 380 nm by a Plate Spectrophotome-
ter (Varioskan Flash; Thermo Scientiﬁc, Boston, MA,  USA)
in  standard black 96-well plates. Enzymatic activity was
expressed as nmol/min/mg protein.
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.6. Quantitative analyses of ﬂavonoids
For evaluation of cellular uptake and mitochondrial
ccumulation of ﬂavonoids, SH-SY5Y cells were seeded
n  60-mm PLL dishes (1 × 106 cell/dish) or 90-mm dishes
3  × 106 cell/dish), respectively. Quercetin and luteolin dis-
olved  in ethanol (ﬁnal concentration in the medium, 0.5%)
ere  added at 10 M.  After incubation, cells were washed
ith ice-cold PBS twice and harvested with 1 mL  of the
ame  buffer. Protein concentration was determined using
he  BCA Protein Assay kit. After centrifugation (1200 × g
or  5 min  at 4 ◦C), ﬂavonoids were extracted from cell pel-
ets  or culture medium with 100 L of methanol containing
%  acetic acid by sonication for 1 min  using an Astrason
L2020 Ultrasonic Processor (Heat Systems, Farmingdale,
Y, USA).
Mitochondrial fractions were obtained from treated
ells according to the method described in Section 2.4 and
avonoids  were extracted as described above. The protein
oncentration was determined using the BCA Protein assay
it.  Kaempferol was added as an internal standard (ﬁnal
oncentration, 5 M)  to determine ﬂavonoid contents
n obtained extracts. After centrifugation (20,000 × g for
0  min  at 4 ◦C), samples were used for high-performance
iquid chromatography analyses with a column of TSK-
el  ODS-80Ts (4.6 × 150 mm;  Tosoh, Tokyo, Japan) and a
obile  phase of 50% methanol with 0.5% H3PO4 at a ﬂow
ate  1 mL/min. Flavonoids were detected at 365 nm using a
PD-20A  UV Detector (Shimadzu, Kyoto, Japan).
.7. Western blotting analyses for MAO-A protein
MAO-A protein in SH-SY5Y cells was detected using
estern blotting analyses. SH-SY5Y cells were seeded on
0-mm  PLL dishes (1 × 106 cell/dish) and, after incuba-
ion for 24 h, treated with 10 M quercetin or luteolin
or a further 24 h. Cells were washed twice with ice-cold
BS, harvested and suspended in 20 mM HEPES (pH 7.4)
ontaining 150 mM NaCl, 1 mM ethylenediamine tetra-
cetic  acid, 1% Triton X100, 0.5% sodium deoxycholate,
.1% sodium dodecyl sulfate (SDS) and a Protease Inhibitor
ocktail (Roche). After incubation for 1 h on ice with peri-
dic  shaking, the suspension was centrifuged (20,000 × g
or  20 min  at 4 ◦C). Protein concentration was determined
sing the BCA Protein Assay kit.
Extracted proteins were separated by
DS–polyacrylamide gel electrophoresis and transferred
nto polyvinylidene diﬂuoride membranes (Amersham
ybond-P; GE Healthcare, Piscataway, NJ, USA). After
locking with 5% fat-free milk, membranes were treated
ith  antibody against MAO-A (Santa Cruz Biotechnology,
anta Cruz, CA, USA) and anti-rabbit IgG horseradish
eroxidase-linked antibody (GE Healthcare). For detec-
ion  of -actin on the same membranes, anti-MAO-A
ntibodies were removed by stripping buffer (Amer-
ham, Buckinghamshire, UK) and membranes treated
ith mouse anti--actin antibody (Sigma-Aldrich). Theecondary antibody for -actin was anti-mouse IgG (GE
ealthcare). Protein bands were visualized with Amer-
ham  ECL plus Western Blotting Detection Reagents (GE
ealthcare) using a LAS-3000 UV Mini Luminescent Imageports 1 (2014) 639–649 641
Analyzer  (Fujiﬁlm, Tokyo, Japan). MAO-A protein bands
were  quantiﬁed using ImageJ v1.47 (National Institutes
of  Health, Bethesda, MD,  USA) and normalized to that of
-actin.
2.8.  Statistical analyses
Signiﬁcance  was analyzed using one-way ANOVA with
the  Tukey multiple comparison test (p < 0.05) or Student’s
t-test (p < 0.05).
3. Results
3.1. Cell viability and stability of ﬂavonoids in the
medium
Our previous study [19] demonstrated that quercetin
and its O-methylated metabolite accumulated in the brain
tissue  of quercetin-administered rats. Those data sug-
gested that the catechol group of the B ring of quercetin and
luteolin  can be subjected to O-methylation by the action of
catechol-O-methyl transferase to produce the correspond-
ing  O-methylated derivatives tamarixetin (4′-O-methyl
quercetin), isorhamnetin (3′-O-methyl quercetin) as well
as  diosmetin (4′-O-methyl luteolin) and chrysoeriol (3′-O-
methyl  luteolin), respectively (Fig. 1).
Therefore, we selected isorhamnetin and diosmetin as
the  representative O-methylated metabolites of quercetin
and  luteolin, respectively, and their effects on cell viabil-
ity  were compared with those of their non-methylated
originals (Fig. 2). Luteolin and diosmetin signiﬁcantly
lowered cell viability by incubation for 24 h at 100 M
(Fig.  2-B), whereas quercetin and its O-methylated metabo-
lite  isorhamnetin did not show such lowering effects at
≤100  M (Fig. 2-A).
Fig. 3-A shows the effect of ascorbic acid on the stability
of  quercetin, luteolin and their O-methylated metabolites
in  cell-free culture medium. In the absence of ascorbic
acid, both quercetin and isorhamnetin were unstable in
the  culture medium, and their amounts were decreased,
respectively, to 3% and 10% of initials after 24-h incu-
bation. However, contents of quercetin and isorhamnetin
changed to 55% and 42% in the presence of ascorbic acid
at  500 M respectively. Neither luteolin nor diosmetin
contents changed irrespective of the presence of ascorbic
acid  at the same conditions.
This  result suggested that ﬂavonols quercetin and
isorhamnetin were unstable in the culture medium (and
different from the ﬂavones luteolin and diosmetin).
Flavonols seem to be liable to auto-oxidation during incu-
bation  because ascorbic acid can serve as a hydrophilic
antioxidant, which seems to protect them from auto-
oxidation in the culture medium. Interestingly, quercetin
(50  M)  signiﬁcantly lowered cell viability in the presence
of  ascorbic acid (Fig. 3-B), suggesting that (similar to lute-
olin)  it could induce cytotoxicity in SH-SY5Y cells at higher
concentrations. It was, therefore, decided that the con-
centration of quercetin and luteolin should be limited to
≤10  M for evaluation of their effects on MAO-A activity
and protein levels in cells. In contrast to quercetin, isorham-
netin  (50 M)  did not show cytotoxic effects even in the
642 Y. Bandaruk et al. / Toxicology Reports 1 (2014) 639–649
 ﬂavoneFig. 1. Structures of the ﬂavonol quercetin, the
presence of ascorbic acid. Hence, different to quercetin,
the O-methylated metabolites of quercetin barely induce
cytotoxic effects. Ascorbic acid (500 M)  did not affect cell
viability  (data not shown).
3.2.  Distribution of quercetin and luteolin in SH-SY5Y
cells and the culture medium
Fig.  4 shows HPLC chromatograms for the extract
from cell fractions (I, III) and culture medium (II, IV)
after incubation with SH-SY5Y cells for 1 h (A) and 24 h
(B).  Quercetin appeared in both chromatograms of 1-h
incubation (Fig. 4-A, I, II), although it was completely extin-
guished  in the chromatogram of 24-h incubation (Fig. 4-B,
I,  II). O-Methylated quercetin was only detected in the
chromatograms of 24-h incubation (Fig. 4-B, I, II). In con-
trast,  luteolin was detected in cell fractions and culture
medium after incubation of both 1 h (Fig. 4-A, III, IV) and
24  h (Fig. 4-B, III, IV). The cellular content of quercetin
(3 nmol/mg protein) and luteolin (2.3 nmol/mg protein)
reached a maximal level transiently after incubation for 15
and  30 min, respectively (Fig. 4-C). Then, cellular contents
of  quercetin and luteolin decreased rapidly within 2 h and luteolin, and their O-methylated metabolites.
were  maintained at relatively stable levels. Cellular con-
tent  of quercetin decreased slowly from 2 to 24 h and
disappeared completely at 24 h of incubation (Fig. 4-C, I),
whereas  content of luteolin remained at a relatively higher
level  and accounted for 1.2 nmol/mg protein after incuba-
tion  for 24 h (Fig. 4-C, III). In the culture medium, quercetin
content decreased rapidly from 10 to 2 M during the ﬁrst
15  min  of incubation, and then decreased gradually during
24  h until complete disappearance (Fig. 4-C, II), whereas
luteolin content in the medium decreased gradually and
did  not disappear completely even after 24 h of incubation
(Fig. 4-C, IV).
Quercetin and luteolin were converted to their O-
methylated metabolites, in which O-methylation occurred
at  the catechol group of the ring B (Fig. 1). O-Methylated
metabolites were found in both cell fractions and culture
medium after incubation of 24 h (Fig. 4-B and -C).
3.3.  Accumulation of quercetin and luteolin in
mitochondrial fractions
Quercetin  and luteolin were rapidly transferred and
reached to mitochondria of SH-SY5Y cells within 15 min
Y. Bandaruk et al. / Toxicology Reports 1 (2014) 639–649 643
Fig. 2. Effect of quercetin, luteolin and their O-methylated metabolites
on the viability of SH-SY5Y cells. SH-SY5Y cells were treated for 24 h
with quercetin (A; gray), isorhamnetin (A; black), luteolin (B; gray) or
diosmetin (B; black). Cell viability was measured as described in the
Materials and methods section. Values were calculated as the percentage
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Fig. 3. Effect of ascorbic acid on the stability of quercetin, luteolin and
their O-methylated metabolites in the culture medium (A) and cell viabil-
ity  in the presence of ﬂavonols (B). (A) Flavonoids were added to cell-free
culture medium without (gray) or with (black) 500 M ascorbic acid at
a  ﬁnal concentration of 10 M and incubated for 24 h. Values are calcu-
lated as percent of zero time-treated control. (B) Cells were treated for
24  h with 10 or 50 M quercetin or isorhamnetin without (gray) or with
(black) 500 M ascorbic acid. Cell viability was  measured as described in
the  Materials and methods section using Cell Proliferation Reagent WST-
1.  Values are calculated as the percentage of vehicle-treated (gray bar) orf vehicle-treated control and are the mean ± SD from ﬁve independent
eterminations. Signiﬁcant differences from controls were evaluated by
he  Student’s t-test (*p < 0.01, **p < 0.001).
fter treatment with the cultured cell (Fig. 5). Maximal
ontents of ﬂavonoids in mitochondrial fractions obtained
rom  treated cells were 2 nmol/mg protein for quercetin
incubation for 60 min) and 3.3 nmol/mg protein for lute-
lin  (incubation for 30 min) (Fig. 5). Similar to whole-cell
ractions, quercetin disappeared completely from mito-
hondrial fractions after incubation for 24 h (Fig. 5, I).
uteolin and its O-methylated metabolite were present
n  mitochondria even after 24 h of incubation at 1.2 and
.8  nmol/mg protein, respectively (Fig. 5, II).
.4.  Effect of ascorbic acid on quercetin content in cell
ractions and the culture mediumThe effects of ascorbic acid on the distribution of
uercetin and its O-methylated metabolites in cell frac-
ions  and culture medium after incubation for 24 h are
hown  in Fig. 6. Similarly to the cell-free culture mediumascorbic acid-treated (black bar) controls and are the mean ± SD from ﬁve
independent determinations. Signiﬁcant differences from controls were
evaluated by the Student’s t-test (*p < 0.05).
(Fig. 3-A), addition of ascorbic acid prevented disappear-
ance of quercetin in the cell fractions and the culture
medium. It was  apparent that ascorbic acid protected
quercetin from auto-oxidation to allow its accumulation
in cell fractions and the culture medium upon 24-h
incubation. O-Methylated metabolites of quercetin also
accumulated at higher levels as compared with those in
the  absence of ascorbic acid (Fig. 6).
3.5. Effects of quercetin and luteolin on MAO-A activity
of mitochondrial fractions
The  effects of quercetin and luteolin on MAO-A activity
in  mitochondrial fractions obtained from cells pretreated
with each ﬂavonoid at 1 and 10 M for 1 h are shown in
Fig.  7-A. Quercetin and luteolin lowered MAO-A activity
signiﬁcantly, so both ﬂavonoids were direct inhibitors of
the  MAO-A reaction in SH-SY5Y cells.
The effects of quercetin and luteolin at 10 M on
MAO-A activity after 24 h of incubation are shown in
Fig.  7-B. Luteolin could decrease the MAO-A activity of
644 Y. Bandaruk et al. / Toxicology Reports 1 (2014) 639–649
Fig. 4. Distribution of quercetin, luteolin and their O-methylated metabolites in SH-SY5Y cells and culture medium. HPLC chromatograms of quercetin (I,
II) and luteolin (III, IV) in SH-SY5Y cell extracts (I, III) and culture medium (II, IV) after incubation for 1 h (A) or 24 h (B); Concentrations of quercetin (I, II),
luteolin  (III, IV) and their O-methylated derivatives in SH-SY5Y cells (I, III) and culture medium (II, IV) (C). SH-SY5Y cells were treated with 10 M (ﬁnal
concentration)  quercetin or luteolin. Flavonoids were extracted and quantiﬁed using HPLC as described in the Materials and methods section.
Y. Bandaruk et al. / Toxicology Reports 1 (2014) 639–649 645
Fig. 4. (Continued.)
Fig. 5. Accumulation of quercetin and luteolin in mitochondrial fractions of SH-SY5Y cells. Cells were seeded on 90-mm dishes and time-dependently
treated with 10 M (ﬁnal concentration) of quercetin (I) or luteolin (II). Mitochondrial fractions were isolated and ﬂavonoids extracted and quantiﬁed
using  HPLC as described in the Materials and methods section. Quercetin (white diamond), O-methylated metabolites of quercetin (black square), luteolin
(white  circle), O-methylated metabolites of luteolin (black triangle).
646 Y. Bandaruk et al. / Toxicology Reports 1 (2014) 639–649
Fig. 6. Effect of ascorbic acid on the distribution of quercetin and its O-methylated metabolites in cell fractions and culture medium after incubation for
24  h. Concentration of quercetin in cell factions (I) and culture medium (II). Cells were seeded on PLL dishes and treated with 10 M quercetin for 24 h in
the  presence or absence of 200 M ascorbic acid. quercetin (gray bar), O-methylated metabolites of quercetin: (black bar).
Fig. 7. Effect of quercetin and luteolin on MAO-A activity in mitochondrial
fractions of pretreated SH-SY5Y cells. (A) SH-SY5Y cells were treated with
1  or 10 M of quercetin or luteolin. After 1 h of incubation, mitochondrial
fractions were isolated. MAO-A activity of the fractions was  measured as
described in the Materials and methods section. (B) SH-SY5Y cells were
incubated for 24 h with 10 M (ﬁnal concentration) of quercetin in the
presence or absence of ascorbic acid at 200 M,  or 10 M (ﬁnal concentra-
tion) of luteolin. MAO-A activity in mitochondrial fractions was  measured
as described previously.
Values  are the mean ± SD from independent triplicate determinations
for each experiment. Signiﬁcant differences were evaluated by one-way
ANOVA with the Tukey multiple comparison test (p < 0.05).
Fig. 8. Effects of quercetin and luteolin on levels of MAO-A protein in SH-
SY5Y cells. SH-SY5Y cells were treated with 10 M (ﬁnal concentration)
of quercetin or luteolin for 24 h. Levels of MAO-A protein were quantiﬁed
using western blotting analyses as prescribed in the Materials and meth-
ods section. Density was quantiﬁed and normalized to that of -actin.
Values are the mean ± SD from independent triplicate determinations
for each experiment. Signiﬁcant differences were evaluated by one-way
ANOVA with the Tukey multiple comparison test (p < 0.05).
isolated mitochondria slightly (but signiﬁcantly).
Quercetin exerted an inhibitory effect only in the presence
of  ascorbic acid.
3.6.  Effects of quercetin and luteolin on levels of MAO-A
protein
Effects of quercetin and luteolin on levels of MAO-A  pro-
tein  in SH-SY5Y cells after 24 h of incubation are shown in
Fig.  8. Luteolin did not affect the protein levels of MAO-
A.  Coexistence of quercetin with ascorbic acid also did not
show  a signiﬁcant effect (data not shown).4. Discussion
Our previous work demonstrated that luteolin was
superior to quercetin with regard to inhibition of MAO-A
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ctivity in mitochondrial fractions obtained from mouse
rains  (though both ﬂavonoids possessed the strongest
nhibitory effect among the ﬂavonoids tested [13]). In the
resent  study, we compared the effect of quercetin with
hat  of luteolin on MAO-A activity using the human neu-
oblastoma SH-SY5Y cell line as a model of serotoninergic
euronal cells because MAO-A (but not MAO-B) is known
o  be expressed in this cell [20].
First, we estimated the cytotoxicity of quercetin, lute-
lin  and their O-methylated metabolites, isorhamnetin and
iosmetin,  respectively. Flavonols quercetin and isorham-
etin  (3′-O-methyl quercetin) had no effect on cell viability
ven  at 100 M,  but ﬂavones luteolin and diosmetin (4′-
-methyl  luteolin) decreased cell viability signiﬁcantly at
00  M after 24 h of incubation (Fig. 2). These ﬁndings sug-
ested  that ﬂavones are more toxic to neuronal cells than
avonols irrespective of free catechol group in the ring B.
t  could be concluded that lack of a hydroxyl group at the
-3  position is critical for the toxicity of ﬂavonoids to SH-
Y5Y  cells. The reason for the slight cytotoxicity of ﬂavonols
ay  be derived from instability in the cell-free culture
edium (Fig. 3-A). Flavonols are known to be susceptible
o  auto-oxidation [21]. Quercetin (but not isorhamnetin)
as cytotoxic at 50 M in coexistence with ascorbic acid
Fig.  3-B). Ascrobic acid protected ﬂavonols from auto-
xidative decomposition and allowed them to exert their
oxic  effect on cells. It is likely that the cytotoxicity of
uercetin at higher concentrations derives from quinone
ormation owing to oxidation of the catechol group [22,23].
-Methylation in the ring B may  suppress the cytotoxicity
f  quercetin by withdrawing the catechol group, result-
ng  in prevention of quinone formation. In contrast, it
s  unlikely that O-methylation in the catechol group of
avones suppresses their cytotoxicity because diosmetin
lso  exerted cytotoxicity at 100 M,  similar to luteolin
Fig. 2-B). It may  indicate that the mechanism for the cyto-
oxicity  of ﬂavones lacking a hydroxyl group at the C-3
osition is distinct from that of ﬂavonols.
Time-course experiments for cellular uptake of
uercetin and luteolin revealed that both ﬂavonoids were
mmediately incorporated into cells and attained a max-
mum  level within 30 min  followed by a rapid decrease
Fig. 4-C). Complete disappearance of quercetin from cell
ractions  and culture medium after 24 h of incubation
ecause of its susceptibility to auto-oxidation implies that
uercetin  does not function in the cell after long-term
ncubation, which is different from the effect of luteolin.
owever, intracellular accumulation of quercetin was
ound  to be comparable with that of luteolin in the pres-
nce  of ascorbic acid (Fig. 6). On the basis of time-course
xperiments shown in Fig. 4-C, accumulation of ﬂavonoids
n  SH-SY5Y cells may  be divided into two stages. In the
rst  stage, ﬂavonoids are attached to cell membranes
nd/or penetrate into the cytosol rapidly by simple
iffusion, thereby leading to maximal accumulation. In
he  second stage, cellular concentration of ﬂavonoids
s modulated by the balance between their efﬂux and
euptake into cells. This modulation may  be well balanced
or  a long time in the case of luteolin, because it exists in
 stable state in cells. Second peak appeared in the time
ourse of cellular luteolin concentration at around 8-hports 1 (2014) 639–649 647
incubation, although the reason of this phenomenon is not
known.
O-Methylated metabolites of quercetin and lute-
olin were found in both cell fractions and culture
medium (Fig. 4-B), suggesting that ﬂavonoids are sub-
jected  (at least partly) to transformation by catechol-O-
methyltransferase, and that the products of this metabolic
conversion efﬂuxed from the cell. Reports have suggested
that glucuronide and/or sulfate conjugates yield quercetin
metabolites in cultured cells [19,24]. However, metabolites
of  quercetin/luteolin other than O-methylated derivatives
were not found in cell fractions or culture medium (data
not  shown). Therefore, O-methylation is the main way of
metabolic  conversion of ﬂavonoids in SH-SY5Y cells. This
O-methylation may  interfere with the inhibition of MAO-
A  activity by ﬂavones and ﬂavonols because O-methylated
metabolites have been reported to lack the inhibitory effect
on  MAO-A [13].
The  targets of quercetin and luteolin as MAO-A
inhibitors in SH-SY5Y cells are mitochondria, because
MAO-A is located exclusively in the outer mitochondrial
membrane [25]. The present study clearly demonstrates
that quercetin and luteolin are transferred into mitochon-
dria immediately after addition to cultured cells (Fig. 5).
Fiorani  et al. [26] reported that quercetin was  readily trans-
ported  into mitochondrial fractions to exert its function if
incubated  with Jurkat human T lymphoblast cells. It has
also  been suggested that quercetin and other structurally
related ﬂavonoids prevent production of hydrogen perox-
ide  by targeting mitochondrial particles [26]. Quercetin is
likely  to be imbedded into the lipid membranes or bound to
some  molecules located in the membranes resulting in the
inhibition  of the activity of MAO-A located in mitochondria
outer membranes. Furthermore, Jones et al. [27] stated that
ﬂavonoids  inhibit the process responsible for mitochon-
drial dysfunction to oppose neurodegeneration. Therefore,
mitochondria serve as targets of quercetin and luteolin in
these  nerve cells.
Initially,  luteolin accumulated in mitochondrial frac-
tions at higher concentrations than quercetin, and its
content decreased very slowly. Higher accumulation of
luteolin  in mitochondria initially may  be because of its
higher  hydrophobicity (ClogP of quercetin and luteolin are
1.5  and 2.31, respectively [13]). In addition, luteolin accu-
mulated in mitochondria of SH-SY5Y cells even after 24 h
of  incubation, even though quercetin disappeared com-
pletely  in mitochondrial fractions (Fig. 5). We  compared
the effect of quercetin and luteolin on MAO-A activity
in isolated mitochondrial fractions of SH-SY5Y cells pre-
treated  for 1 h and 24 h. Contents of quercetin and luteolin
reached to their maximal level in mitochondria during 1 h
of  incubation and it is therefore likely to attenuate MAO-A
activity directly as shown in Fig. 7-A. After incubation for
24  h, quercetin needs ascorbic acid to inhibit mitochondrial
MAO-A activity (Fig. 7-B), corresponding to the preven-
tive effect of ascorbic acid on its disappearance in the cell
fraction  (Fig. 6, I).Daily  consumption of ﬂavonoids originating from plant
foods  may allow accumulation of these compounds in brain
tissue  and for them to exert prolonged effects on nerve cells
by  affecting cell signaling pathways and the resulting gene
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expression [28–30]. Therefore, we examined the possibil-
ity  of quercetin and luteolin modulating MAO-A protein
levels after 24 h of incubation with SH-SY5Y cells. Neither
quercetin nor luteolin showed any tendency to decrease
levels of MAO-A protein in SH-SY5Y cells (Fig. 8). Hence,
both  ﬂavonoids can attenuate MAO-A activity, but it is
unlikely  they will affect cellular signaling pathways that
result  in modulation of MAO-A protein expression.
The concentrations required for inhibition of MAO-A
activity in this in vitro study (≤10 M)  are higher than those
observed under physiological conditions. However, several
evidences based on animal studies have shown that dietary
ﬂavonoids can cross the blood–brain barrier and accu-
mulate in brain tissue after long-term feeding [19,28,31].
Therefore, long-term intake of quercetin, luteolin and other
structurally related ﬂavonoids may  modulate mitochon-
drial MAO-A activity in nerve cells. Flavonoids such as
quercetin and luteolin are present in the blood stream and
tissues  exclusively as their conjugated metabolites (glu-
curonides and/or sulfates) [32]. However, previously we
implied  that microglia can deliver the aglycone to nerve
cells  by deconjugation of conjugated metabolites in the
brain  [33]. Therefore, quercetin and luteolin could exert
their  physiological functions in the form of aglycone in
brain  tissue.
5.  Conclusion
The ﬂavonol quercetin and ﬂavone luteolin can move
into mitochondria and attenuate MAO-A activity directly
in  neuronal cells. Stability in the cell medium and distri-
bution in the target site should be taken into account for
estimating the modulatory effect of ﬂavonoids on MAO-A
activity by interpretation from in vitro cell culture studies.
Mechanism underlying the modulation of MAO-A activity
in  nerve cells by ﬂavonoids needs further evaluation.
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